196 related articles for article (PubMed ID: 31348149)
41. Hematologic effects of recombinant factor VIIa combined with hemoglobin-based oxygen carrier-201 for prehospital resuscitation of swine with severe uncontrolled hemorrhage due to liver injury.
Arnaud F; Hammett M; Philbin N; Scultetus A; McCarron R; Freilich D
Blood Coagul Fibrinolysis; 2008 Oct; 19(7):669-77. PubMed ID: 18832908
[TBL] [Abstract][Full Text] [Related]
42. High ratio plasma resuscitation does not improve survival in pediatric trauma patients.
Cannon JW; Johnson MA; Caskey RC; Borgman MA; Neff LP
J Trauma Acute Care Surg; 2017 Aug; 83(2):211-217. PubMed ID: 28481839
[TBL] [Abstract][Full Text] [Related]
43. The development of hemoglobin solutions as red cell substitutes: hemoglobin solutions.
Gould SA; Sehgal LR; Sehgal HL; Moss GS
Transfus Sci; 1995 Mar; 16(1):5-17. PubMed ID: 10155705
[TBL] [Abstract][Full Text] [Related]
44. Preparation, characterization and in vivo investigation of blood-compatible hemoglobin-loaded nanoparticles as oxygen carriers.
Lu M; Zhao C; Wang Q; You G; Wang Y; Deng H; Chen G; Xia S; Zhao J; Wang B; Li X; Shao L; Wu Y; Zhao L; Zhou H
Colloids Surf B Biointerfaces; 2016 Mar; 139():171-9. PubMed ID: 26708138
[TBL] [Abstract][Full Text] [Related]
45. Calculations of oxygen transport by red blood cells and hemoglobin solutions in capillaries.
Vadapalli A; Goldman D; Popel AS
Artif Cells Blood Substit Immobil Biotechnol; 2002 May; 30(3):157-88. PubMed ID: 12066873
[TBL] [Abstract][Full Text] [Related]
46. All hemoglobin-based oxygen carriers are not created equally.
Buehler PW; Alayash AI
Biochim Biophys Acta; 2008 Oct; 1784(10):1378-81. PubMed ID: 18206989
[TBL] [Abstract][Full Text] [Related]
47. Supra-plasma expanders: the future of treating blood loss and anemia without red cell transfusions?
Tsai AG; Vázquez BY; Hofmann A; Acharya SA; Intaglietta M
J Infus Nurs; 2015; 38(3):217-22. PubMed ID: 25871869
[TBL] [Abstract][Full Text] [Related]
48. Pharmaceutical aspects of hemoglobin-based oxygen carriers.
Awasthi V
Curr Drug Deliv; 2005 Apr; 2(2):133-42. PubMed ID: 16305414
[TBL] [Abstract][Full Text] [Related]
49. Freeze-dried plasma mitigates the dilution effects of a hemoglobin-based oxygen carrier (HBOC-201) in a model of resuscitation for hemorrhage and hemodilution.
Meledeo MA; Peltier GC; McIntosh CS; Taylor AS; Bynum JA; Pusateri AE; Cap AP
J Trauma Acute Care Surg; 2019 Jul; 87(1S Suppl 1):S83-S90. PubMed ID: 31246911
[TBL] [Abstract][Full Text] [Related]
50. Proposition of a technique to assess the vasoactive effects of hemoglobin-based oxygen carrying solutions in vivo: preliminary results in the rabbit aorta.
Caron A; Menu P; Labrude P; Vigneron C
Artif Cells Blood Substit Immobil Biotechnol; 1998 May; 26(3):293-308. PubMed ID: 9635122
[TBL] [Abstract][Full Text] [Related]
51. Accuracy of continuous noninvasive hemoglobin monitoring for the prediction of blood transfusions in trauma patients.
Galvagno SM; Hu P; Yang S; Gao C; Hanna D; Shackelford S; Mackenzie C
J Clin Monit Comput; 2015 Dec; 29(6):815-21. PubMed ID: 25753142
[TBL] [Abstract][Full Text] [Related]
52. Development of Time-course Oxygen Binding Analysis for Hemoglobin-based Oxygen Carriers.
Okamoto Y; Sugisaki S; Suga K; Umakoshi H
Anal Sci; 2017; 33(8):953-956. PubMed ID: 28794333
[TBL] [Abstract][Full Text] [Related]
53. The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable.
Gould SA; Moore EE; Hoyt DB; Ness PM; Norris EJ; Carson JL; Hides GA; Freeman IH; DeWoskin R; Moss GS
J Am Coll Surg; 2002 Oct; 195(4):445-52; discussion 452-5. PubMed ID: 12375748
[TBL] [Abstract][Full Text] [Related]
54. Blood substitutes as pharmacotherapies in clinical practice.
Jahr JS; Walker V; Manoochehri K
Curr Opin Anaesthesiol; 2007 Aug; 20(4):325-30. PubMed ID: 17620840
[TBL] [Abstract][Full Text] [Related]
55. RBC Transfusion Improves Cerebral Oxygen Delivery in Subarachnoid Hemorrhage.
Dhar R; Zazulia AR; Derdeyn CP; Diringer MN
Crit Care Med; 2017 Apr; 45(4):653-659. PubMed ID: 28169942
[TBL] [Abstract][Full Text] [Related]
56. Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients.
Shaz BH; Dente CJ; Nicholas J; MacLeod JB; Young AN; Easley K; Ling Q; Harris RS; Hillyer CD
Transfusion; 2010 Feb; 50(2):493-500. PubMed ID: 19804568
[TBL] [Abstract][Full Text] [Related]
57. Perfluorocarbon Gas Transport: an Overview of Medical History With Yet Unrealized Potentials.
Spiess BD
Shock; 2019 Oct; 52(1S Suppl 1):7-12. PubMed ID: 29677087
[TBL] [Abstract][Full Text] [Related]
58. A new era in oxygen therapeutics? From perfluorocarbon systems to haemoglobin-based oxygen carriers.
Charbe NB; Castillo F; Tambuwala MM; Prasher P; Chellappan DK; Carreño A; Satija S; Singh SK; Gulati M; Dua K; González-Aramundiz JV; Zacconi FC
Blood Rev; 2022 Jul; 54():100927. PubMed ID: 35094845
[TBL] [Abstract][Full Text] [Related]
59. Current Challenges in the Development of Acellular Hemoglobin Oxygen Carriers by Protein Engineering.
Benitez Cardenas AS; Samuel PP; Olson JS
Shock; 2019 Oct; 52(1S Suppl 1):28-40. PubMed ID: 29112633
[TBL] [Abstract][Full Text] [Related]
60. HBOC-201, hemoglobin glutamer-250 (bovine), Hemopure (Biopure Corporation).
Jahr JS; Moallempour M; Lim JC
Expert Opin Biol Ther; 2008 Sep; 8(9):1425-33. PubMed ID: 18694360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
